As medical researchers and clinicians, we are concerned about the proposed reductions in funding for the U.S. National ...

Journal of Nuclear Medicine February 2025, jnumed.124.268967; DOI: https://doi.org/10.2967/jnumed.124.268967 Cancer therapy has advanced with molecularly targeted ...

Multisystemic inflammation might be a key pathophysiologic mechanism in post–coronavirus disease 2019 (post-COVID) syndrome. N,N- diethyl-2-(2-(4-(2-fluoroethoxy)phenyl)5,7dimethylpyrazolo[1,5a] ...

Journal of Nuclear Medicine April 2025, jnumed.124.269203; DOI: https://doi.org/10.2967/jnumed.124.269203 ...

TO THE EDITOR: Radiopharmaceuticals for PET imaging are regulated as drugs by the U.S. Food and Drug Administration (FDA) through several offices within the Center for Drug Evaluation and Research, ...

The field of nuclear medicine is going through a renaissance with significant investment by a biotechnology and pharmaceutical industry finally recognizing the benefits of the theranostic paradigm.

The study of the human phenome is essential for understanding the complexities of wellness and disease and their transitions, with molecular imaging being a vital tool in this exploration. Molecular ...

The Highlights Lecture, presented at the closing session of each SNMMI Annual Meeting, was originated and presented for more than 30 y by Henry N. Wagner, Jr., MD. Beginning in 2010, the duties of ...

Dr. Richard Zimmermann is a distinguished figure in the field of nuclear medicine and radiopharmaceuticals. With a strong academic foundation, he holds MSc degrees in organic chemistry, physical ...

The term theranostics has clearly become a buzzword. To a large extent, this is due to the success of prostate-specific membrane antigen (PSMA)–targeted radioligands. These ligands can be labeled with ...

Diagnostic radiopharmaceuticals are used in nuclear medicine scans to help physicians diagnose disease, assess treatment response, and determine eligibility for treatments. This article focuses on ...